Maravai Lifesciences Holdings (MRVI) Gross Margin (2020 - 2025)
Historic Gross Margin for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 13.58%.
- Maravai Lifesciences Holdings' Gross Margin fell 331200.0% to 13.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.07%, marking a year-over-year decrease of 251600.0%. This contributed to the annual value of 41.79% for FY2024, which is 67300.0% down from last year.
- Per Maravai Lifesciences Holdings' latest filing, its Gross Margin stood at 13.58% for Q3 2025, which was down 331200.0% from 16.39% recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Gross Margin registered a high of 84.55% during Q2 2022, and its lowest value of 13.58% during Q3 2025.
- Moreover, its 5-year median value for Gross Margin was 52.65% (2023), whereas its average is 55.54%.
- In the last 5 years, Maravai Lifesciences Holdings' Gross Margin skyrocketed by 278300bps in 2021 and then plummeted by -473500bps in 2023.
- Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Gross Margin stood at 82.87% in 2021, then fell by -11bps to 73.99% in 2022, then decreased by -29bps to 52.65% in 2023, then crashed by -35bps to 34.28% in 2024, then plummeted by -60bps to 13.58% in 2025.
- Its Gross Margin stands at 13.58% for Q3 2025, versus 16.39% for Q2 2025 and 16.49% for Q1 2025.